Investigations to characterize a new anti-arrhythmic drug, ORG 6001 including a simple test for calcium antagonism

British Journal of Pharmacology
L A SalakoJ H Wittig

Abstract

1 The compound Org 6001 (3alpha-amino-2beta-hydroxy-5alpha-androstan-17-one hydrochloride) was found in recent experiments to exhibit anti-arrhythmic activity. Evidence is presented in this paper concerning its mode of action. 2 Org 6001 was 1.8 times more potent than procaine as a local anaesthetic on desheathed frog nerve. 3 Org 6001 had no effect on the resting potential of isolated cardiac muscle of rabbit, but greatly reduced the maximum rate of depolarization tion (MRD). The action potential duration TAPD) WAS MARGINALLY PROLONGED IN ATRIAL AND VENTRICULAR MUSCLE. 4 Org 6001 preferentially shortened APD in that part of the Purkinje system in which APD is normally longer than elsewhere, so that APD

References

Sep 1, 1975·The Journal of Pharmacy and Pharmacology·B B VargaftigH van Riezen
Jan 1, 1975·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·E M Vaughan Williams
Mar 1, 1973·Circulation Research·L A HarrisonA G Wallace
Jul 1, 1973·American Heart Journal·J WittigA G Wallace
Jan 1, 1971·Annual Review of Physiology·E A Johnson, M Lieberman
Jan 1, 1972·British Journal of Pharmacology·B N Singh, E M Vaughan Williams
Jun 1, 1971·European Journal of Pharmacology·A S Graca, P A van Zwieten
Mar 1, 1970·Circulation Research·R J MyerburgB F Hoffman
Aug 1, 1970·British Journal of Pharmacology·B N Singh, E M Vaughan Williams
Sep 1, 1958·British Journal of Pharmacology and Chemotherapy·E M VAUGHAN WILLIAMS
Dec 1, 1961·British Journal of Pharmacology and Chemotherapy·E M WILLIAMS, L SZEKERES
Jan 1, 1964·Circulation Research·J HAN, G K MOE
Mar 1, 1962·The Journal of Physiology·L Szekeres, E M Williams

❮ Previous
Next ❯

Citations

Mar 7, 1980·European Journal of Pharmacology·J Tamargo
Jul 1, 1983·Journal of Steroid Biochemistry·G H PhillippsP G Dolamore
Jan 1, 1982·Toxicon : Official Journal of the International Society on Toxinology·A L HarveyE Karlsson
Jan 1, 1981·General Pharmacology·R J Marshall, E Winslow
Aug 1, 1979·British Journal of Pharmacology·K A KaneJ R Parratt
Jun 25, 2005·Vascular Pharmacology·Regilane M SilvaVietla S N Rao
Jan 1, 1984·Annals of the New York Academy of Sciences·E M Vaughan Williams
Jun 1, 1982·British Journal of Pharmacology·T J Campbell, E M Vaughan Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.